143 related articles for article (PubMed ID: 30604096)
1. Synthesis, characterization and anticonvulsant activity of new azobenzene-containing VV-hemorphin-5 bio photoswitch.
Todorov PT; Peneva PN; Georgieva SI; Tchekalarova J; Vitkova V; Antonova K; Georgiev A
Amino Acids; 2019 Mar; 51(3):549-563. PubMed ID: 30604096
[TBL] [Abstract][Full Text] [Related]
2. Anticonvulsant evaluation and docking analysis of VV-Hemorphin-5 analogues.
Todorov P; Rangelov M; Peneva P; Todorova N; Tchekalarova J
Drug Dev Res; 2019 Jun; 80(4):425-437. PubMed ID: 30681179
[TBL] [Abstract][Full Text] [Related]
3. Potential anticonvulsant activity of novel VV-hemorphin-7 analogues containing unnatural amino acids: synthesis and characterization.
Todorov P; Peneva P; Tchekalarova J; Georgieva S
Amino Acids; 2020 Apr; 52(4):567-585. PubMed ID: 32206933
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization and anticonvulsant activity of new series of N-modified analogues of VV-hemorphin-5 with aminophosphonate moiety.
Todorov P; Peneva P; Tchekalarova J; Rangelov M; Georgieva S; Todorova N
Amino Acids; 2019 Nov; 51(10-12):1527-1545. PubMed ID: 31576456
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the structure-activity relationship in a series of new LVV- and VV-hemorphin-7 analogues designed as potential anticonvulsant agents.
Todorov P; Georgieva S; Peneva P; Tchekalarova J
Amino Acids; 2022 Feb; 54(2):261-275. PubMed ID: 34978007
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, molecular docking, electrochemical and fluorimetric analysis of new caffeic and cinnamic acid-conjugated hemorphin derivatives designed as potential anticonvulsant and antinociceptive agents.
Todorov P; Georgieva S; Peneva P; Nikolov S; Rangelov M; Todorova N; Pechlivanova D; Tchekalarova J
Bioorg Chem; 2024 Feb; 143():107063. PubMed ID: 38150935
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationship study on new hemorphin-4 analogues containing steric restricted amino acids moiety for evaluation of their anticonvulsant activity.
Todorov P; Peneva P; Tchekalarova J; Georgieva S; Rangelov M; Todorova N
Amino Acids; 2020 Oct; 52(10):1375-1390. PubMed ID: 33011823
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization and evaluation of anti-hyperalgesia, anticonvulsant and antioxidant activity of novel VV-hemorphin-5 analogs.
Todorov P; Georgieva S; Tchekalarova J; Peneva P; Mateeva P; Assenov B; Dzhambazova E; Pechlivanova D
Arch Pharm (Weinheim); 2023 Oct; 356(10):e2300267. PubMed ID: 37532631
[TBL] [Abstract][Full Text] [Related]
9. Antinociceptive Effects of VV-Hemorphin-5 Peptide Analogues Containing Amino phosphonate Moiety in Mouse Formalin Model of Pain.
Assenov B; Pechlivanova D; Dzhambazova E; Peneva P; Todorov P
Protein Pept Lett; 2021; 28(4):442-449. PubMed ID: 32798365
[TBL] [Abstract][Full Text] [Related]
10. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
Löscher W; Hönack D
Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, characterization, and biological study of new synthetic opioid hemorphin-4 peptides containing sterically restricted nonnatural amino acids.
Todorov P; Georgieva S; Trapella C; Chakarov K; Tchekalarova J; Pechlivanova D; Cheshmedzhieva D; Fantinati A; Illuminati D
Arch Pharm (Weinheim); 2024 Jul; 357(7):e2400052. PubMed ID: 38578075
[TBL] [Abstract][Full Text] [Related]
12. Valorphins alter physicochemical characteristics of phosphatidylcholine membranes: Datasets on lipid packing, bending rigidity, specific electrical capacitance, dipole potential, vesicle size.
Vitkova V; Staneva G; Hazarosova R; Georgieva SI; Valkova I; Antonova K; Todorov P
Data Brief; 2022 Dec; 45():108716. PubMed ID: 36426033
[TBL] [Abstract][Full Text] [Related]
13. Valerenic acid and Valeriana officinalis extracts delay onset of Pentylenetetrazole (PTZ)-Induced seizures in adult Danio rerio (Zebrafish).
Torres-Hernández BA; Del Valle-Mojica LM; Ortíz JG
BMC Complement Altern Med; 2015 Jul; 15():228. PubMed ID: 26168917
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization and nociceptive screening of new VV-hemorphin-5 analogues.
Todorov P; Peneva P; Pechlivanova D; Georgieva S; Dzhambazova E
Bioorg Med Chem Lett; 2018 Oct; 28(18):3073-3079. PubMed ID: 30078474
[TBL] [Abstract][Full Text] [Related]
15. Anticonvulsant activity of β-caryophyllene against pentylenetetrazol-induced seizures.
de Oliveira CC; de Oliveira CV; Grigoletto J; Ribeiro LR; Funck VR; Grauncke AC; de Souza TL; Souto NS; Furian AF; Menezes IR; Oliveira MS
Epilepsy Behav; 2016 Mar; 56():26-31. PubMed ID: 26827298
[TBL] [Abstract][Full Text] [Related]
16. Family of hemorphins: co-relations between amino acid sequences and effects in cell cultures.
Blishchenko EY; Sazonova OV; Kalinina OA; Yatskin ON; Philippova MM; Surovoy AY; Karelin AA; Ivanov VT
Peptides; 2002 May; 23(5):903-10. PubMed ID: 12084521
[TBL] [Abstract][Full Text] [Related]
17. Additive anticonvulsant effects of creatine supplementation and physical exercise against pentylenetetrazol-induced seizures.
Rambo LM; Ribeiro LR; Oliveira MS; Furian AF; Lima FD; Souza MA; Silva LF; Retamoso LT; Corte CL; Puntel GO; de Avila DS; Soares FA; Fighera MR; Mello CF; Royes LF
Neurochem Int; 2009 Sep; 55(5):333-40. PubMed ID: 19393274
[TBL] [Abstract][Full Text] [Related]
18. Anticonvulsant activities of myo-inositol and scyllo-inositol on pentylenetetrazol induced seizures.
Nozadze M; Mikautadze E; Lepsveridze E; Mikeladze E; Kuchiashvili N; Kiguradze T; Kikvidze M; Solomonia R
Seizure; 2011 Mar; 20(2):173-6. PubMed ID: 21074457
[TBL] [Abstract][Full Text] [Related]
19. Anticonvulsant effects of cyclosporin A on pentylenetetrazole-induced seizure and kindling: modulation by nitricoxidergic system.
Homayoun H; Khavandgar S; Dehpour AR
Brain Res; 2002 Jun; 939(1-2):1-10. PubMed ID: 12020845
[TBL] [Abstract][Full Text] [Related]
20. Anticonvulsant effects of acetaminophen in mice: Comparison with the effects of nonsteroidal anti-inflammatory drugs.
Suemaru K; Yoshikawa M; Tanaka A; Araki H; Aso H; Watanabe M
Epilepsy Res; 2018 Feb; 140():22-28. PubMed ID: 29227797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
